These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 13600193)

  • 1. [Phenols & ether-soluble aromatic hydroxy acids in the blood of patients with renal diseases & the mechanism of their renal excretion].
    GIOVANNETTI S; CIONI L; DELLA SANTA M
    Minerva Nefrol; 1958; 5(2):79-84. PubMed ID: 13600193
    [No Abstract]   [Full Text] [Related]  

  • 2. Significance of circulating phenols in anemia of renal disease.
    DUNN I; WEINSTEIN IM; MAXWELL MH; KLEEMAN CR
    Proc Soc Exp Biol Med; 1958 Oct; 99(1):86-8. PubMed ID: 13601776
    [No Abstract]   [Full Text] [Related]  

  • 3. Blood phenol in renal insufficiency.
    WARRES HL
    J Urol; 1954 Feb; 71(2):134-43. PubMed ID: 13131449
    [No Abstract]   [Full Text] [Related]  

  • 4. Photolabile protection of alcohols, phenols, and carboxylic acids with 3-hydroxy-2-naphthalenemethanol.
    Kulikov A; Arumugam S; Popik VV
    J Org Chem; 2008 Oct; 73(19):7611-5. PubMed ID: 18781799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Spectrophotometric method of determining the concentration of phenols in the blood].
    Pomerants OG; Kvitsinskaia EA; Durovich PG
    Lab Delo; 1981; (6):341-3. PubMed ID: 6169910
    [No Abstract]   [Full Text] [Related]  

  • 6. Are 4-hydroxy-2(E)-nonenal derived mercapturic acids and (1)H NMR metabonomics potential biomarkers of chemically induced oxidative stress in the kidney?
    Mally A; Amberg A; Hard GC; Dekant W
    Toxicology; 2007 Feb; 230(2-3):244-55. PubMed ID: 17184893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protein & lipid pictures in renal patients].
    DIAZ-RUBIO M; JANER DEL VALLE C
    Rev Clin Esp; 1958 Aug; 70(4):209-18. PubMed ID: 13614838
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal excretion of phenols in patients with chronic renal insufficiency.
    Schück O; Vidláková M; Erben J
    Nephron; 1989; 53(3):279-80. PubMed ID: 2797350
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diagnostic value of quantitative determination of phenols in the blood in schizophrenia].
    POROSHINA AA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1955 Apr; 55(4):266-8. PubMed ID: 14387270
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma amino acids and ether-soluble phenols in uremia.
    SCHMIDT EG; McELVAIN NF; BOWEN JJ
    Am J Clin Pathol; 1950 Mar; 20(3):253-61. PubMed ID: 15432305
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of alcohol on cytochrome p450 arachidonic acid metabolism and blood pressure in rats and its modulation by red wine polyphenolics.
    Cowpland C; Su GM; Murray M; Puddey IB; Croft KD
    Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):183-8. PubMed ID: 16487260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Citrate in blood during renal insufficiency].
    NORDMANN R; MARTY A; NORDMANN J
    Rev Fr Etud Clin Biol; 1959 May; 4(5):454-61. PubMed ID: 13658725
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum lipid profile and plasma fatty acid composition in hemodialysis patients--comparison with chronic kidney disease patients.
    Nakamura N; Fujita T; Kumasaka R; Murakami R; Shimada M; Shimaya Y; Osawa H; Yamabe H; Okumura K
    In Vivo; 2008; 22(5):609-11. PubMed ID: 18853755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The peripheral blood leukocytes in chronic renal insufficiency.
    RIIS P; STOUGAARD J
    Dan Med Bull; 1959 May; 6(3):85-90. PubMed ID: 13663587
    [No Abstract]   [Full Text] [Related]  

  • 15. [Various aspects of the blood coagulation mechanism in kidney disease].
    FELICI W; BACCHETTA V; GRILLI R
    Minerva Pediatr; 1958 Dec; 10(50):1508-14. PubMed ID: 13643940
    [No Abstract]   [Full Text] [Related]  

  • 16. Oxalic Acid as a uremic toxin.
    Mydlík M; Derzsiová K
    J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High mobility group box chromosomal protein 1 in patients with renal diseases.
    Sato F; Maruyama S; Hayashi H; Sakamoto I; Yamada S; Uchimura T; Morita Y; Ito Y; Yuzawa Y; Maruyama I; Matsuo S
    Nephron Clin Pract; 2008; 108(3):c194-201. PubMed ID: 18311084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifactor Xa activity correlates to thrombin generation time, platelet contractile force and clot elastic modulus following ex vivo enoxaparin exposure in patients with and without renal dysfunction.
    Brophy DF; Martin EJ; Best AM; Gehr TW; Carr ME
    J Thromb Haemost; 2004 Aug; 2(8):1299-304. PubMed ID: 15304034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
    Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS
    Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenofovir and renal toxicity.
    AIDS Patient Care STDS; 2004 Oct; 18(10):615-6. PubMed ID: 15633256
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.